Comment
doi: 10.4161/cc.9.3.11045.
Epub 2010 Feb 1.
The promise of novel androgen receptor antagonists
Affiliations
- PMID: 20130446
- DOI: 10.4161/cc.9.3.11045
Item in Clipboard
Comment
The promise of novel androgen receptor antagonists
Cell Cycle.
.
Free article
No abstract available
Comment on
-
Small molecule screening reveals a transcription-independent pro-survival function of androgen receptor in castration-resistant prostate cancer.Cell Cycle. 2009 Dec 15;8(24):4155-67. doi: 10.4161/cc.8.24.10316. Epub 2009 Dec 13. Cell Cycle. 2009. PMID: 19946220 Free PMC article.
Similar articles
-
A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer.Proc Natl Acad Sci U S A. 2021 Mar 30;118(13):e2012748118. doi: 10.1073/pnas.2012748118. Proc Natl Acad Sci U S A. 2021. PMID: 33753479 Free PMC article.
-
UHRF1 promotes androgen receptor-regulated CDC6 transcription and anti-androgen receptor drug resistance in prostate cancer through KDM4C-Mediated chromatin modifications.Cancer Lett. 2021 Nov 1;520:172-183. doi: 10.1016/j.canlet.2021.07.012. Epub 2021 Jul 12. Cancer Lett. 2021. PMID: 34265399
-
Discovery of BMS-641988, a novel and potent inhibitor of androgen receptor signaling for the treatment of prostate cancer.Cancer Res. 2009 Aug 15;69(16):6522-30. doi: 10.1158/0008-5472.CAN-09-1111. Epub 2009 Aug 4. Cancer Res. 2009. PMID: 19654297
-
The complex role of AR signaling after cytotoxic insult: implications for cell-cycle-based chemotherapeutics.Cell Cycle. 2007 Jun 1;6(11):1307-13. doi: 10.4161/cc.6.11.4353. Epub 2007 Jun 26. Cell Cycle. 2007. PMID: 17568191 Review.
-
Novel therapeutic strategies for castration resistant prostate cancer: inhibition of persistent androgen production and androgen receptor mediated signaling.J Urol. 2011 Mar;185(3):787-94. doi: 10.1016/j.juro.2010.10.042. Epub 2011 Jan 15. J Urol. 2011. PMID: 21239012 Review.
Cited by
-
Galbanic acid decreases androgen receptor abundance and signaling and induces G1 arrest in prostate cancer cells.Int J Cancer. 2012 Jan 1;130(1):200-12. doi: 10.1002/ijc.25993. Epub 2011 May 9. Int J Cancer. 2012. PMID: 21328348 Free PMC article.
-
Recent progress in targeting cancer.Aging (Albany NY). 2011 Dec;3(12):1154-62. doi: 10.18632/aging.100421. Aging (Albany NY). 2011. PMID: 22228887 Free PMC article. Review.
-
Androgen receptor serine 81 mediates Pin1 interaction and activity.Cell Cycle. 2012 Sep 15;11(18):3415-20. doi: 10.4161/cc.21730. Epub 2012 Aug 16. Cell Cycle. 2012. PMID: 22894932 Free PMC article.
-
CDK9 regulates AR promoter selectivity and cell growth through serine 81 phosphorylation.Mol Endocrinol. 2010 Dec;24(12):2267-80. doi: 10.1210/me.2010-0238. Epub 2010 Oct 27. Mol Endocrinol. 2010. PMID: 20980437 Free PMC article.
-
Checkpoint Kinase 2 Negatively Regulates Androgen Sensitivity and Prostate Cancer Cell Growth.Cancer Res. 2015 Dec 1;75(23):5093-105. doi: 10.1158/0008-5472.CAN-15-0224. Epub 2015 Nov 16. Cancer Res. 2015. PMID: 26573794 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
